Literature DB >> 19464788

MicroRNAs: novel regulators in the hallmarks of human cancer.

Kai Ruan1, Xiaoguang Fang, Gaoliang Ouyang.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs of 18-25 nucleotides in length that function as negative regulators. miRNAs post-transcriptionally regulate gene expression by either inhibiting mRNA translation or inducing mRNA degradation, and participate in a wide variety of physiological and pathological cellular processes. Recent reports have revealed that the deregulation of miRNAs correlates with various human cancers and is involved in the initiation and progression of human cancers. miRNAs can act as oncogenes or tumor suppressors to inhibit the expression of cancer-related target genes and to promote or suppress tumorigenesis in various tissues. Therefore, abnormal miRNA expression can be regarded as a common feature of human cancers, and the identification of miRNAs and their respective targets may provide potential diagnostic and prognostic tumor biomarkers and new therapeutic strategies to treat cancers. In the present review, we discuss the emerging roles of miRNAs in the hallmarks of human cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464788     DOI: 10.1016/j.canlet.2009.04.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  167 in total

Review 1.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

3.  Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population.

Authors:  Ying Zeng; Qing-Min Sun; Nan-Nan Liu; Guang-Hui Dong; Jie Chen; Li Yang; Bin Wang
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

Review 4.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

Review 5.  Large non-coding RNAs: missing links in cancer?

Authors:  Maite Huarte; John L Rinn
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

6.  Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.

Authors:  Leila Sisic; Daniel Vallböhmer; Nikolas H Stoecklein; Susanne Blank; Thomas Schmidt; Christiane Driemel; Birte Möhlendick; Wolfram T Knoefel; Margarete Odenthal; Katja Ott
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

7.  A G-quadruplex DNA-based, label-free and ultrasensitive strategy for microRNA detection.

Authors:  Li Yan; Yiyong Yan; Lei Pei; Wei Wei; Jing Zhao
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

8.  Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells.

Authors:  Deniz Mortazavi; Mohammadreza Sharifi
Journal:  Cytotechnology       Date:  2018-08-02       Impact factor: 2.058

9.  MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.

Authors:  Michaela B Kirschner; Yuen Yee Cheng; Nicola J Armstrong; Ruby C Y Lin; Steven C Kao; Anthony Linton; Sonja Klebe; Brian C McCaughan; Nico van Zandwijk; Glen Reid
Journal:  Mol Oncol       Date:  2014-12-02       Impact factor: 6.603

10.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.